Financial planner
Hot data: Net value of fund Reward ranking
Net worth forecast Private placement income
Shenwanlingxin Pharmaceutical Pioneer Stock A
(005433)
Net unit value: 0.5284( 2.762% )
purchase consultation
Add self selection

Shenwanlingxin Pharmaceutical Pioneer Stock A

(005433) View with mobile phone
Scan QR code
Open this page with your phone
Stock Medium risk
Jian Financial Information Rating:

Fund performance (i.e. risk adjusted returns) ranks among the top 84% of funds of the same type. The rating does not include funds with less than two years of performance, as well as closed-end funds, money market funds and capital guaranteed funds.

>> View Performance
(--) Latest valuation: --
Unit net value
zero point five two eight four
Rise and fall
2.76%
Increase in recent March
-16.25%
Increase in recent one year
-35.81%
Increase in recent three years
-54.86%
Data date: June 26, 2024
Date of establishment: November 16, 2020
Cumulative net value per unit: RMB 0.5284
Latest scale: 180 million
Accumulated dividends: 0 yuan
survey essential information Historical net worth Notice rate a bonus Fund No Fund
Market trend Net worth forecast Historical net worth Historical returns
share
Ranking percentage (monthly) Ranking percentage (quarter) Ranking percentage (year)
Fund performance and ranking
Date range (up to 2024-06-26) Nearly half a year Last year since this year on 2023 2022 In recent 3 years Since its establishment
Net value growth rate -24.20% -35.81% -27.67% -7.64% -18.43% -54.86% -47.16%
Similar ranking (common stock) 921/955 860/873 1022/1026 322/914 312/793 562/602 --
Same class average (common stock) -1.28% -14.02% -3.98% -11.05% -20.10% -31.19% --
Annualized rate of return (%) -48.40% -35.81% -56.73% -7.64% -18.43% -18.29% -13.06%
Quartile ranking
Top 10 positions
Data date: 2024-03-31
Stock Abbreviation Latest price Rise and fall Proportion in net worth (%) Shareholding fund (share) service
Shareholding ratio Change from the previous period Shareholding fund Change from the previous period
Kangwei Century -- -- 9.98% -5.22% four -155 consultation
Wuzhong, Jiangsu -- -- 9.42% 70.65% seven -134 consultation
Outside the mountain -- -- 9.27% -9.30% four -193 consultation
Jiu'an Medical -- -- 9.07% - twenty-nine -292 consultation
Preh Ophthalmology -- -- 8.44% 4.84% fifteen -408 consultation
Huasha Ophthalmology Department -- -- 8.41% 7.54% eight -458 consultation
Xishan Technology -- -- 8.38% -18.88% four -460 consultation
He's ophthalmology -- -- 8.02% -0.62% four -138 consultation
Runda Medical -- -- 5.58% - twenty-eight -150 consultation
Great East -- -- 5.40% 8.22% two -24 consultation
Asset allocation
Data date: 2024-03-31
Industry distribution
Data date: 2024-03-31
Stock selection style
Fund rating
Rating classification Comprehensive rating Profitability Performance stability Risk resistance market timing Benchmark tracking capability Excess earning capacity Overall cost
Stock
--
-- -- --
Rating deadline: 2024-03-31
Fund announcement
Fund News
More>>
Shenwanlingxin Pharmaceutical Pioneer Stock Securities Investment Fund (Shenwanlingxin Pharmaceutical Pioneer Stock A) Fund Product Capital Summary of Fund Product Information 2024-06-25
Indicative announcement on updating the summary of fund product information for some funds under Shen Wanlingxin Fund Management Co., Ltd Informative announcement, fund 2024-06-25
Shenwan Lingxin Fund Management Co., Ltd.'s suggestive announcement on the adjustment of stock valuation method of its funds Fund valuation adjustment 2024-06-18
Announcement of Shenwan Lingxin Fund Management Co., Ltd. on the New Consignment Institutions of Some Funds Increase the agency 2024-05-08
Shenwan Lingxin Pharmaceutical Pioneer Equity Securities Investment Fund First Quarter Report of 2024 investment portfolio 2024-04-22
Indicative announcement of some funds under Shen Wanlingxin Fund Management Co., Ltd. in the first quarter of 2024 Fund quarterly report tips 2024-04-22
Shen Wanlingxin Pharmaceutical Pioneer Equity Securities Investment Fund 2023 Annual Report Annual report of the Fund 2024-03-29
Indicative Announcement on 2023 Annual Report of Some Funds of Shenwan Lingxin Fund Management Co., Ltd Fund Annual Report Tips 2024-03-29
Announcement of Shenwan Lingxin Fund Management Co., Ltd. on the New Consignment Institutions of Some Funds Increase the agency 2024-01-30
Indicative announcement on the report of the fourth quarter of 2023 of some funds of Shenwan Lingxin Fund Management Co., Ltd Fund quarterly report tips 2024-01-22
Fund No
More>>
Fund
There are no posts about this fund, I want to post>>
Fund information | Subscription redemption | legal document | Sales organization | Holder structure | Top Ten Holders
Subscription redemption of Shenwanlingxin Pharmaceutical Pioneer Stock A (005433)
Start date Deadline
No corresponding data!
Reporting period Total shares at the beginning of the period Total shares at the end of the period Total subscription shares during the period (copies) Total redemption units during the period (share) Net redemption shares during the period Net redemption ratio
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Shen Wanlingxin Pharmaceutical Pioneer Stock A (005433) Holder Structure
No corresponding data!
Reporting period
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Top Ten Holders of Shen Wanlingxin Pharmaceutical Pioneer Stock A (005433)
No corresponding data!
Report date
S/N Name of holder Shares held Proportion in total shares (%)
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Historical net value of Shenwanlingxin Pharmaceutical Pioneer Stock A (005433)
Start date Deadline
Please enter a valid start and end date!
date Unit net value (yuan) Accumulated net value (yuan) Net value growth rate
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
whole | periodic report | Dividend report | interim report | Fund rate change | Major events
Start date Deadline
Please enter a valid start and end date!
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Historical dividend | financial index | Income Statement | Fund Balance Sheet
No corresponding data!
It is a normal phenomenon that the net value of the unit declines and the income temporarily declines due to fund dividends, share conversion, etc
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
No corresponding data!
No corresponding data!
The following posts recommend popular funds~
Position change of Shen Wanlingxin Pharmaceutical Pioneer Stock A (005433)
Report date
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Shen Wanlingxin Pharmaceutical Pioneer Stock A (005433) holds all shares
Report date
S/N Securities code Securities Abbreviation Market value of position (yuan) Proportion to net fund value (%) Number of shares held (shares) Proportion in total share capital of the company (%) Shareholding fund (piece)
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Bonds held by Shenwanlingxin Pharmaceutical Pioneer Stock A (005433)
Report date
S/N Bond code Bond abbreviation Market value of bonds (yuan) Proportion to net worth (%) Bond holding fund (piece)
*Note: Sina Finance reminds that the above data are provided by the partners for reference only. For transactions, please refer to the officially announced data.
Open subscription: no
Service charge for purchase: --% --%
Initial purchase amount: --Yuan
Cangshi Wealth Management: an independent fund sales platform under Sina.com, subject to the supervision of China Securities Regulatory Commission and Shanghai Pudong Development Bank
Consulting financial planner
Add self selection
Buy funds with the financial planner client!
Recent Visits Discretionary fund
Fund abbreviation Latest net value growth rate service
-- -- -- --
See more>>
You have no self selected fund, please add~
See more>> Administration
Basic information Investment Style
Fund information Fund rate Subscription redemption Historical net worth Dividend information Fund announcement legal document Sales organization Holder structure Top Ten Holders
Top 10 positions Change in position Asset allocation Industry distribution Stock Details Bonds held Stock selection style
Financial position Fund rating
financial index Income Statement Fund Balance Sheet
Morningstar Rating Haitong Rating Galaxy Rating Investment promotion rating Jian Financial Information Rating
Hot sales of the same kind
Fund abbreviation Latest net value Recent March service
Similar funds
Fund abbreviation Latest net value Recent March service
Investment promotion sports one point two two three zero 5.16%
Investment promotion sports one point two four six zero 5.15%
Cathay Pacific China Securities zero point five seven seven seven 5.13%
ICBC Media zero point seven seven four nine 4.77%
Chinese Business Computing zero point eight two eight four 4.65%
Rongtong Zhongzheng zero point nine five four six 4.64%
Chinese Business Computing zero point eight three three zero 4.64%
Golden Eagle Technology one point one one one eight 4.36%
Golden Eagle Technology one point one zero four nine 4.35%
Harvest Information one point zero four zero six 3.94%
Peer fund
Fund abbreviation Latest net value Recent March service
Shen Wanling Letter zero point nine zero nine six 4.15%
Shen Wanling Letter zero point nine zero five zero 4.13%
Shen Wanling Letter zero point six three three nine 3.68%
Shen Wanling Letter zero point six three eight eight 3.67%
Shen Wanling Letter zero point six six three five 3.27%
Shen Wanling Letter zero point six six zero four 3.25%
Shen Wanling Letter zero point six nine eight three 3.22%
Shen Wanling Letter zero point seven seven seven five 2.98%
Shen Wanling Letter zero point seven seven one five 2.98%
Shen Wanling Letter zero point five seven eight four 2.77%
Haoji Recommendation

The quotations of Shanghai and Shenzhen stocks, funds, bonds, Hong Kong stocks, US stocks, domestic futures, foreign exchange, gold, etc., unless otherwise specified, are all real-time quotations; In other markets, the delay time shall be at least 15 minutes. The market data and other materials provided free of charge by Sina Finance are from partners, which are only for the purpose of obtaining information from users and do not constitute investment advice. Sina Finance and its partners will not be responsible for the error, deformity, delay of the information provided on this page or any action taken by relying on this information. There are risks in the market, so investment should be cautious.